Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume

被引:25
|
作者
Beal, Eliza W. [1 ]
Mehta, Rittal [1 ]
Merath, Katiuscha [1 ]
Tsilimigras, Diamantis I. [1 ]
Hyer, J. Madison [1 ]
Paredes, Anghela [1 ]
Dillhoff, Mary E. [1 ]
Cloyd, Jordan [1 ]
Ejaz, Aslam [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, Div Surg Oncol, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
关键词
Travel distance; Hospital volume; Hepatocellular carcinoma; RADIOFREQUENCY ABLATION; SURGICAL MARGINS; LIVER-DISEASE; CANCER; MORTALITY; SURVIVAL; TRANSPLANTATION; ASSOCIATION; MANAGEMENT; CENTERS;
D O I
10.1007/s11605-019-04233-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundData on the impact of hospital volume and travel distance on patient outcomes after major abdominal surgery remain poorly defined. We sought to characterize the relationship of travel distance, hospital volume, and long-term outcomes of patients undergoing surgical resection of hepatocellular carcinoma (HCC).MethodsThe 2004-2015 National Cancer Database was used to identify patients who underwent resection of HCC. Patients were stratified according to travel distance and hospital volume quartiles, and multivariable regression models were utilized to examine the impact of travel distance, hospital volume, and travel distance/hospital volume on overall survival (OS).ResultsAmong the 12,266 patients identified, procedures included wedge/segmental resections (N=7354, 59.9%), hemi-hepatectomy (N=4003, 32.6%), and extended hepatectomy (N=909, 7.5%). Stratifying data into quartiles, travel distance to surgical care was 5.7miles (mi), >5.7-14.2mi, >14.2-44.4mi, and 44.4mi, while hospital volume quartiles determined on the hospital level were 1 case per year, 1.1-4, 4.1-12.5, and 12.5. On multivariable analysis, increased hospital volume was associated with decreased hazard of mortality (HR 0.69, 95% CI 0.45-0.82, p<0.001). Travel distance was not significantly associated with hazard of mortality. Furthermore, only hospital volume was associated with mortality (HR 0.67, 95% CI 0.56-0.80, p<0.001) after controlling for both travel distance and hospital volume.ConclusionsOnly hospital volume was associated with increased hazard of mortality. The benefits of undergoing resection for HCC at a high-volume hospital appear to outweigh the inconvenience of longer travel distances.
引用
收藏
页码:1425 / 1434
页数:10
相关论文
共 50 条
  • [21] Bile Leakage After Hepatic Resection for Hepatocellular Carcinoma: Does It Impact the Short- and Long-term Outcomes?
    Shehta, Ahmed
    Farouk, Ahmed
    Said, Rami
    El Nakeeb, Ayman
    Aboelenin, Ahmed
    Elshobary, Mohamed
    Fouad, Amgad
    Elghawalby, Ahmed Nabieh
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (10) : 2070 - 2081
  • [22] The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection
    Yanagaki, Mitsuru
    Haruki, Koichiro
    Taniai, Tomohiko
    Igarashi, Yosuke
    Yasuda, Jungo
    Furukawa, Kenei
    Onda, Shinji
    Shirai, Yoshihiro
    Tsunematsu, Masashi
    Ikegami, Toru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (04) : 453 - 461
  • [23] von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma
    Schwarz, Christoph
    Fitschek, Fabian
    Mittlboeck, Martina
    Saukel, Veronika
    Bota, Simona
    Ferlitsch, Monika
    Ferlitsch, Arnulf
    Bodingbauer, Martin
    Kaczirek, Klaus
    GUT AND LIVER, 2020, 14 (02) : 218 - 224
  • [24] Seizing tumor factors for mortality and survival outcomes following liver resection in Indonesia's hepatocellular carcinoma patients
    Sihardo, Lam
    Lalisang, Arnetta Naomi Louise
    Syaiful, Ridho Ardhi
    Putra, Afid Brilliana
    Mazni, Yarman
    Putranto, Agi Satria
    Lalisang, Toar Jean Maurice
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2025, 29 (01) : 11 - 20
  • [25] Favorable outcomes of surgical resection for extrahepatic recurrent hepatocellular carcinoma
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Nakayama, Hisashi
    Moriguchi, Masamichi
    Aramaki, Osamu
    Yamazaki, Shintaro
    Teramoto, Kenichi
    Yoshida, Nao
    Kobayashi, Naoya
    Tsuji, Shingo
    Higaki, Tokio
    HEPATOLOGY RESEARCH, 2020, 50 (08) : 978 - 984
  • [26] Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
    Rungsakulkij, Narongsak
    Suragul, Wikran
    Mingphruedhi, Somkit
    Tangtawee, Pongsatorn
    Muangkaew, Paramin
    Aeesoa, Suraida
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (06) : 110 - 120
  • [27] Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
    Shang, Jin
    Xu, Shanling
    Zhang, Jiaxing
    Ran, Xuting
    Bai, Lang
    Tang, Hong
    ONCOTARGET, 2017, 8 (65) : 109723 - 109731
  • [28] Adverse Outcomes in Patients with Postoperative Ascites after Liver Resection for Hepatocellular Carcinoma
    Chan, Kun-Ming
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Yu, Ming-Chin
    Lee, Wei-Chen
    Chen, Miin-Fu
    WORLD JOURNAL OF SURGERY, 2012, 36 (02) : 392 - 400
  • [29] Viral Status and Treatment Efficacy in Recurrent Hepatocellular Carcinoma After Primary Resection
    Cheng, Hou-Ying
    Hu, Rey-Heng
    Hsiao, Chih-Yang
    Ho, Ming-Chih
    Wu, Yao-Ming
    Lee, Po-Huang
    Ho, Cheng-Maw
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (08) : 1594 - 1610
  • [30] Readmission After Surgical Resection and Transplantation for Hepatocellular Carcinoma: A Retrospective Cohort Study
    Khan, Sidrah
    Chidi, Alexis
    Hrebinko, Katherine
    Kaltenmeier, Christof
    Nassour, Ibrahim
    Hoehn, Richard
    Geller, David
    Tsung, Allan
    Tohme, Samer
    AMERICAN SURGEON, 2022, 88 (01) : 83 - 92